Clindamycin

  • TRADE NAMES: Aclinda; BB; Benzaclin (Dermik); Cleocin (Pfizer); Cleocin-T (Pfizer); Clindacin; Clindagel (Galderma); Clindets (Stiefel); Dalacin; Dalacin C; Dalacine; Galecin; Sobelin
  • INDICATIONS: Various serious infections caused by susceptible organisms
  • CLASS: Antibiotic; lincosamide
  • HALF-LIFE: 2–3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Cisatracurium, Erythromycin, Kaolin, Mivacurium, Neostigmine, Pyridostigmine, Rocuronium, Saquinavir

PREGNANCY CATEGORY: B

See also separate entry for the combination product clindamycin/tretinoin.

Our database has 62 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
OTIC.
RENAL.
OTHER.


Page last updated 06/03/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top